Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir.
Tchesnokov EP, Feng JY, Porter DP, Götte M. · 2019
Read Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir. by Tchesnokov EP, Feng JY, Porter DP, Götte M. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6520719.txt.
Description
Tchesnokov and co-authors work out how remdesivir blocks the Ebola virus polymerase. Their study appeared in Viruses. Remdesivir is a prodrug of an adenosine analogue. It was in clinical development for Ebola virus disease. Its exact blocking mechanism was still unclear.
The team used purified polymerase from Ebola and RSV. The active form of remdesivir competed with ATP for a place in new RNA. Both viral enzymes took it up with like ease. Human mitochondrial polymerase rejected it about 500-fold more. Once built in, the drug did not stop the next step. Chain growth stalled mainly five positions later. The authors call this delayed chain termination.
Catalog record
| CREATOR | Tchesnokov EP, Feng JY, Porter DP, Götte M. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |